Credicorp Ltd. Common Stock (BAP)

Total Costs & Expenses

PEN 18.68B

TTM · Period ending: · PEN

BAP logo

BAP Total Costs & Expenses

Latest reportedPEN 18.68B PEN
BAP TTM Total Costs & Expenses · PEN (PEN 3.82B → PEN 18.68B)
High-resolution chart · PNG

BAP total costs & expenses history

Trailing twelve months (TTM) · PEN. Each value covers four complete reported quarters.

Credicorp Ltd. Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (PEN)
Period endingTotal Costs & Expenses (PEN)
18,676,737,604
18,239,907,604
17,820,805,000
16,707,134,000
18,883,325,000
18,953,686,000
19,034,898,000
19,353,796,000
19,393,041,000
18,891,375,000
18,521,245,000
19,527,713,000
18,364,643,000
17,105,891,000
15,830,066,000
12,677,172,000
11,848,955,000
11,561,757,000
11,700,048,000
12,057,649,000
13,200,531,000
15,310,015,000
16,321,141,000
16,211,473,000
15,338,005,000
13,282,669,000
12,102,578,000
11,651,075,000
11,365,723,000
11,100,807,000
10,925,912,000
10,940,584,000
10,789,621,000
10,811,469,000
10,894,639,000
10,807,746,000
10,758,520,000
10,722,961,000
10,550,902,000
10,584,290,000
10,462,601,000
10,277,877,000
10,042,613,000
9,793,980,000
9,668,229,000
9,545,443,000
9,215,855,000
8,800,013,000
8,428,991,000
8,049,115,000
7,847,935,000
7,606,096,766
7,353,935,236
7,051,398,001
6,715,334,251
7,026,241,671
6,600,065,990
6,131,647,716
7,201,719,551
7,621,363,380
7,436,089,375
7,233,090,829
5,736,983,938
4,433,431,976
4,316,881,151
4,443,656,290
4,583,972,219
4,161,623,757
4,295,055,040
4,645,623,150
4,405,089,643
4,982,446,189
4,916,724,489
4,429,147,680
4,414,702,730
3,869,772,102
3,655,736,853
3,494,878,748
3,395,918,052
3,333,702,201
3,228,984,360
3,092,527,676
2,896,177,785
2,658,968,754
2,670,209,612
2,669,623,433
2,736,370,266
2,665,267,078
2,588,791,745
2,612,896,374
2,748,528,362
2,797,173,613
2,838,771,180
2,845,360,210
2,728,727,506
2,839,776,891
2,957,548,133
3,117,589,732
3,324,978,799
3,550,643,958
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.